Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin with Chemotherapy in Digestive Endocrine Tumors
NCT00448136Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2007
- Primary completion
- Nov 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in gastroenteropancreatic neuroendocrine tumor (GEP-NET), sponsored by Roche. Started Jul 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
gastroenteropancreatic neuroendocrine tumor (GEP-NET)
Beyond the preview
Go deeper on NCT00448136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00448136.